Medigen Vaccine Biologics (ROCO:6547) ROE % Adjusted to Book Value : -0.74% (As of Dec. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Medigen Vaccine Biologics ROE % Adjusted to Book Value?

Medigen Vaccine Biologics's ROE % for the quarter that ended in Dec. 2024 was -2.29%. Medigen Vaccine Biologics's PB Ratio for the quarter that ended in Dec. 2024 was 3.08. Medigen Vaccine Biologics's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was -0.74%.

Medigen Vaccine Biologics ROE % Adjusted to Book Value Historical Data

The historical data trend for Medigen Vaccine Biologics's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medigen Vaccine Biologics ROE % Adjusted to Book Value Chart

Medigen Vaccine Biologics Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-4.32

2.65

-6.71

-4.36

-0.68

Medigen Vaccine Biologics Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-9.41	-1.70	0.30	0.04	-0.74

Competitive Comparison of Medigen Vaccine Biologics's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Medigen Vaccine Biologics's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medigen Vaccine Biologics's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Medigen Vaccine Biologics's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Medigen Vaccine Biologics's ROE % Adjusted to Book Value falls into.

Save Embed

;

Save Embed

;

Medigen Vaccine Biologics ROE % Adjusted to Book Value Calculation

Medigen Vaccine Biologics's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-2.09%	/	3.08
	=	-0.68%

Medigen Vaccine Biologics's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-2.29%	/	3.08
	=	-0.74%

Medigen Vaccine Biologics ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Medigen Vaccine Biologics's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Medigen Vaccine Biologics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medigen Vaccine Biologics Corp (ROCO:6547) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 16, Neihu Road, Lane 120, Floor 7, Section 1, Neihu District, Taipei, TWN, 11493

Website

https://www.medigenvac.com

Medigen Vaccine Biologics Corp is a biopharmaceutical company focusing on developing and producing vaccines and biologics. It is engaged in developing IP-protected cell-culture technologies for vaccine manufacturing. The company develops vaccines and affordable biosimilars to prevent regional infectious diseases. The group generates revenue from manufacturing and selling a range of Covid-19 vaccines and Covid-19 test kits and provides technical services on cellular therapy product quality and cell culture tests.

Medigen Vaccine Biologics Headlines

No Headlines